CLOV vs CTMX
Clover Health Investments Corp (CLOV) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
CLOV currently screens at market cap $1.55B. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the CLOV and CTMX stock pages for the full models.
Not investment advice.